Patients with high levels of CD8+ tumor infiltrating lymphocytes, as assessed by immunohistochemistry [11,12,13], and patients with high ratios of M1 macrophage cells to M2 tumor-associated macrophage (M2TAM) cells in the TME [14] exhibit improved survival. Here, CD8A is linked to neoplasm.